Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Another big one is muscle loss. A new ... weight loss,” Gerhart-Hines said. He explained that GLP-1 agonists don’t work quite as well for weight loss in people with diabetes because the drug ...

They investigated 12 medications — three that the US Food and Drug Administration (FDA) has approved for weight loss and nine it hasn’t. The drugs mimic GLP-1, a hormone the body naturally ...

A weight loss pill would offer more convenience to patients and would be easier to manufacture. The company is set to release key late-stage trial data on the drug, orforglipron, by the middle of ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been ... weight-loss medications more than doubled between 2022 and 2023. Meanwhile, they have also been found to ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...